2/13/19 ASHLAND, OH— Ashland University alumnus Rich Ferrari will be returning to Ashland University in March to give a lecture hosted by the Dauch College of Business and Economics.
“We are delighted to have Rich Ferrari return to campus this semester to present in front of our students and members of the community,” said Dr. Elad Granot, dean of the Dauch College.
Ferrari will be speaking on “The Value of Objectivity” in Myers Convocation Center on March 14 at 11 a.m. The event is free and open to the public.
This presentation is just one part of Ferrari’s overall lecture series titled “Excellent by Choice,” a series that Ferrari has been developing for a number of years.
The organizers of the event are asking those who plan on attending to RSVP by filling out the form at Click here to RSVP.
Ferrari came to Ashland College from Long Island, N.Y., to play lacrosse during the mid-1970s and during his junior year began to develop his personal philosophy that would help guide his life. He has gone on to have a very successful career in the venture capital industry in Silicon Valley.
Ferrari is co-founder of De Novo Ventures, which has $650 million under management and is one of the premier firms dedicated to Medical Devices and Bio-Technology.
Additionally, Ferrari has been a successful CEO of two publicly traded medical technology companies. Cardiovascular Imaging Systems, the first and leading developer of ultrasound imaging catheters that was eventually acquired for $125 million by Boston Scientific. His most recent success, CardioThoracic Systems (CTS), the market leader in disposable instruments and systems for performing minimally invasive beating heart bypass surgery, was acquired by Guidant for $350 million in November 1999.
Ferrari was a co-founder of CTS and the force that led the company to an initial public offering in only seven months, the fastest of any medical technology company in history. Ferrari also co-founded the Medical Technology Group, which spun-off Integrated Vascular Systems that was acquired by Abbot Vascular and Ensure, acquired by J&J.
Ferrari also serves as a faculty member of the Stanford Biodesign Emerging Entrepreneurs Forum as well as a board member for the Stanford Coulter Foundation for Translational Medicine.
Previously, Ferrari held the positions of executive vice president and general manager of ADAC Laboratories. In 1996, he founded Saratoga Ventures, a venture capital partnership that has provided seed financing to startup medical technology companies.
Ferrari is the recipient of the Mallinckrodt Award for Excellence in Medicine and has been a finalist for the Entrepreneur of the Year Award. He holds a Bachelor of Science degree from Ashland University and an MBA from the University of South Florida.
Ashland University, ranked in the top tier of colleges and universities in U.S. News and World Report’s National Universities category for 2018, is a mid-sized, comprehensive private university conveniently located a short distance from Akron, Cleveland and Columbus, Ohio. Religiously affiliated with the Brethren Church, Ashland University (www.ashland.edu) deeply values the individual student and offers a unique educational experience that combines the challenge of strong, applied academic programs with a faculty and staff who build nurturing relationships with their students. ###